DIM.PA PAR
Sartorius Stedim Biotech S.A.
1W: -2.0%
1M: +4.8%
3M: +16.1%
YTD: +16.6%
1Y: +19.0%
3Y: -21.6%
5Y: -60.4%
€208.20 ($234.38)
+2.00 (+0.97%)
Weekly Expected Move ±4.7%
€189
€198
€208
€218
€228
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
#1
of 3
Medical - Instruments & Supplies
Technical Signal Map
1 Bullish
0 Neutral
2 Bearish
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| DIM.PA Sartorius Stedim Biotech S.A. | $20B | 68.9 | 7.1 | 6.5 | 12.1 | 3.8 | 8 | BULLISH | 19.0 |
| ALCJ.PA Crossject S.A. | $80M | -5.2 | 2343.6 | -170.8 | — | -14.7 | 3 | BEARISH | -10.9 |
| EL.PA EssilorLuxottica S.A. | $75B | 26.4 | 12.5 | 10.2 | 10.6 | 10.4 | 7 | BEARISH | -45.1 |
| DIM.PA Sartorius Stedim Biotech S.A. | $20B | 68.9 | 7.1 | 6.5 | 12.1 | 3.8 | 8 | BULLISH | 19.0 |
| ALCJ.PA Crossject S.A. | $80M | -5.2 | 2343.6 | -170.8 | — | -14.7 | 3 | BEARISH | -10.9 |
| EL.PA EssilorLuxottica S.A. | $75B | 26.4 | 12.5 | 10.2 | 10.6 | 10.4 | 7 | BEARISH | -45.1 |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
DIM.PA vs Benchmarks
ROIC
Gross Margin
Op Margin
Net Margin
Revenue Growth
P/E Ratio
ROE
Piotroski F